Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Journal of Biomolecular Structure & Dynamics|January 15, 2020
Discovery of new AKT1 inhibitors by combination of in silico structure based virtual screening approaches and biological evaluationsFilip Fratev, Denisse A Gutierrez, Renato J Aguilera, et al.
Molecular Carcinogenesis|August 3, 2018
A natural molecule, urolithin A, downregulates androgen receptor activation and suppresses growth of prostate cancerNisha R Dahiya, Balaji Chandrasekaran, Venkatesh Kolluru, et al.
Frontiers in Pharmacology|March 13, 2023
A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growthUttara Saran, Balaji Chandrasekaran, Ashish Tyagi, et al.
Frontiers in Pharmacology|June 11, 2024
Corrigendum: A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growthUttara Saran, Balaji Chandrasekaran, Ashish Tyagi, et al.
Molecular Carcinogenesis|September 4, 2013
Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cellsSuman Suman, Vittal Kurisetty, Trinath P Das, et al.
Frontiers in Pharmacology|May 19, 2023
Corrigendum: A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growthUttara Saran, Balaji Chandrasekaran, Ashish Tyagi, et al.
Cells|August 12, 2022
A Comprehensive Transcriptomic Analysis of Arsenic-Induced Bladder CarcinogenesisVaibhav Shukla, Balaji Chandrasekaran, Ashish Tyagi, et al.
Biochemical and Biophysical Research Communications|January 7, 2018
Fenofibrate inhibits mTOR-p70S6K signaling and simultaneously induces cell death in human prostate cancer cellsXin Lian, Junlian Gu, Baoshan Gao, et al.
Oncology Letters|June 23, 2020
ASR488, a novel small molecule, activates an mRNA binding protein, CPEB1, and inhibits the growth of bladder cancerAshish Tyagi, Venkatesh Kolluru, Balaji Chandrasekaran, et al.
Cell Death & Disease|July 25, 2018
Suppression of Notch1 and AKT mediated epithelial to mesenchymal transition by Verrucarin J in metastatic colon cancerDeeksha Pal, Ashish Tyagi, Balaji Chandrasekaran, et al.
Pageof 7